Pet Center, Inc of Los Angeles, CA is voluntarily recalling its 3 oz. bag of Lamb Crunchy’s dog treats (LAM-003) (UPC# 727348200038) with date code 122015, product of USA, because it has the potential to be contaminated with Salmonella.
Bravo is recalling select lots and product(s) of Bravo Pet Food because they have the potential to be contaminated with Listeria monocytogenes.
Every year, there are approximately 4.5 million people bitten by dogs, with children between the ages of five and nine the most likely to be bitten. The good news is that dog bites *are* preventable. It’s up to people, not dogs, to stop dog bites.
Porcine Epidemic Diarrhea virus (PEDv) disease has been added to the reportable disease list in Oregon. The PEDv is a highly contagious coronavirus that affects swine, causing diarrhea and vomiting, and death of 50-100 percent of infected piglets. Adult pigs can become infected but generally do not have mortality.
Oregon Administrative Rules require veterinarians to report certain diseases to the Oregon Department of Agriculture.
The State of Oregon allows for brucellosis vaccination of healthy female beef and dairy cattle over the age of 12 months.
Hospira Recalls One Lot of 0.25% Marcaine™ (Bupivacaine HCI Injection, USP), 10 ml, Single-Dose, Preservative-Free Vial
Hospira has recalled to the user level one lot of 0.25% Marcaine™ (Bupivacaine HCl Injection, USP), 10 mL, Single-dose Vial – Preservative Free (NDC 0409-1559-10), Lot 34-440-DD. The recall is due to a confirmed customer report of discolored solution with visible particles embedded in the glass as well as discolored solution.
Does your pet wear an ID tag? Is it microchipped? These two forms of identification could help you to be reunited with your pet should it become lost.
Hospira, Inc. has recalled one lot of 1% Lidocaine HCI Injection, USP to the user level due to a confirmed customer report of orange and black particulate within the solution and embedded within the glass vial. Hospira has identified the particulate as iron oxide. Risk factors associated with the particulate include the potential for particulate to be injected and/or a delay in therapy.
Hospira, Inc. announced today that on April 2, 2014, it informed customers of a nationwide recall of seven lots of Propofol Injectable Emulsion, USP, to the user level due to a glass defect located on the interior neck of the vial, which was identified during a retain sample inspection where the glass vial contained visible embedded metal particulate. Free-floating metal particulates were also identified in vials upon further analysis.